RADventure started the development of the ROBINSCA system, working with the Erasmus MC (Rotterdam) to support the ROBINSCA trial.

The purpose of this research project is to investigate whether the early detection of an increased risk for cardiovascular disease followed by adequate treatment will reduce cardiovascular related morbidity and mortality. Over 330.000 people of the general population will be addressed to participate. About 39.000 people with an expected increased risk will be randomly assigned to one of the three groups for risk analysis (control versus classical risk factors versus Coronary Artery Calcium score), that will be compared after a follow up period of 5 to 10 years.

The contract was assigned to RADventure in March 2014, based on our experience with screening and screening related research programs.

For more information please visit: http://www.gezondheidsraad.nl/en/publications/prevention/population-screening-act-calcium-score-and-risk-cardiovascular-disease